BioGaia and SCA today signed a long-term collaboration agreement with the aim of
developing new health-targeted products through BioGaia´s probiotic bacteria and
application technologies combined with SCA´s competence in the field of hygiene
products. The objective is to develop products specifically suited to BioGaia´s
and SCA´s distribution networks.
BioGaia´s task will be to develop different patented strains to different
indications, test these in clinical trials and to create formulations which are
specially adapted to the indication. SCA will contribute with patented
technologies in the area of hygiene and have an extensive distribution network
where probiotics can be marketed and sold. The areas of interest are intimate
hygiene products and products for the elderly.
"It is extremely exciting to see what this collaboration can give since both
partners can contribute with both know-how and patented technologies and their
own distribution networks. We are highly impressed with SCA´s ambitions in the
hygiene area and our hope is that we shall be able to develop new products that
can be sold in relatively large volumes through SCA´s distribution net as well
as more specialised products for our own distributors." says Peter Rothschild,
President BioGaia.
"The collaboration is a good example of open innovation, which in this case
involves taking ideas from one's own company and finding an environment outside
where the idea can developed optimally. The fact that there is complementary
competence within both companies was obvious early and we also noted that there
are synergies between our methods of reaching the market. We have really high
hopes for what will come out of this collaboration since we will utilise the
distinctive characteristics that define each of us." says Ingela Torstensson,
Global Head of Research at SCA.
For additional information contact:
Peter Rothschild, President BioGaia Tel: 08-555 293 00
[HUG#1446275]
